✦ LIBER ✦

Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia

✍ Scribed by Letizia Foroni; Gareth Gerrard; Emmanuel Nna; Jamshid Sorouri Khorashad; David Stevens; Bryony Swale; Dragana Milojkovic; Alistair Reid; John Goldman; David Marin

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 230 KB
Volume: 84
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21457

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Heterogenic molecular basis for loss of

Heterogenic molecular basis for loss of ABL1-BCR transcription: Deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia

✍ Ivan F. Loncarevic; Jennifer Römer; Heike Starke; Anita Heller; Cordula Bleck; M 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 881 KB

The objective of this study was to characterize the ABL1-BCR fusion gene in 76 BCR-ABL1-positive chronic myeloid leukemia (CML) patients regarding expression as well as genomic status, to assess the frequency of ABL1-BCR gene deletion in these patients, which has been reported to be an adverse progn

Applicability of an absolute quantitativ

Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patients

✍ Karl-Anton Kreuzer; Ulrich Lass; Stefan Nagel; Heinz Ellerbrok; Georg Pauli; Bär 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 149 KB

Chimeric bcr/abl fusion proteins are thought to be the molecular 'pathogen' of chronic myelogenous leukaemia (CML). Expression levels of the respective fusion RNAs reflect disease progression as well as remission upon therapeutic intervention in CML patients. However, there is no quick and reliable

Bcr-Abl oncogene stimulates jab1 express

Bcr-Abl oncogene stimulates jab1 expression via cooperative interaction of β-catenin and STAT1 in chronic myeloid leukemia cells

✍ Kuei-Ting Yang; Ming-Chung Wang; Jing-Yi Chen; Ming-Chuan Hsu; Wen-Chun Hung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB

## Abstract Jab1, a co‐activator of AP‐1 transcription factor and the fifth subunit of the COP9 signalosome, mediates degradation of the tumor suppressor p53 and p27^Kip1^ and functions as a tumor promoter in different types of human cancer. In this study, we show that inhibition of Bcr‐Abl oncogen